Knight Therapeutics Reports Fourth Quarter and Year End 2019 Results

    NEXT STORY
    PCI Biotech appoints Dr Amir Snapir as Chief Medical Officer
    PREV STORY
    AETERNA ZENTARIS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL AND OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AB Science announces that Phase 2B/3 study evaluating oral in Alzheimer’s disease met its primary endpoint

    author_avatar
    NASDAQ Market News

    Immunocore Secures $130 Million Series B Financing

    author_avatar
    NASDAQ Market News

    TESARO Announces Participation at Two Investor Conferences

    WALTHAM, Mass., Oct. 23, 2017 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...

    author_avatar
    NASDAQ Market News